Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs; IGF2BP1/2/3), as a newly discovered m6A regulator in recent years, promotes the stability and storage of its target mRNA (such as MYC) in an m6A-dependent manner, and has a carcinogenic effect in cancer [39,40]. The gene discussed is IGF2; the disease is cancer.